EAPCI Column

DOI:

EAPCI Fellowship Grants: Why you should apply. An interview with Dr Kasparas Briedis, the 2018 EAPCI Fellowship Grant winner

Why did you apply for an EAPCI Fellowship Grant?

In Lithuania, despite robust clinical facilities, a significant gap existed in heart valve interventions; my ambition was ignited to bridge this gap. The EAPCI Fellowship Grant emerged as a pathway enabling me to acquire international experience and proficiency, imperative for enhancing catheter-based valve implantations in Lithuania. This opportunity addressed the increasing need for highly qualified specialists capable of performing intricate procedures while minimising the risk for complications.

How did you choose your host centre for your EAPCI Fellowship?

The Liverpool Heart and Chest Hospital in the UK, recognised for its extensive adult congenital heart disease program and high rate of heart valve interventions, resonated with my commitment to excellence and specialisation. It was a profound honour to gain insights and learn procedures from world-renowned, leading interventional cardiologists in this high-calibre institution.

What did you focus on during your EAPCI Fellowship?

A concrete focus during my fellowship was to achieve proficiency as an independent primary operator in transcatheter aortic valve implantation (TAVI). I dedicated myself to understanding every potential procedural complication and meticulously mastering steps to ensure procedural success. Beyond technical skills, I was keen to grasp the comprehensive logistical steps, including patient referrals, outpatient clinics, and multidisciplinary team (MDT) meetings, establishing a solid foundation in this service.

Did the EAPCI Fellowship fulfil your objectives?

The EAPCI Fellowship proved transformative: working within the English National Health Service (NHS) enriched my understanding of principles like clinical effectiveness, risk management, and continuous learning and development. I actively engaged in multiple facets of structural heart interventions, contributing to, and learning from MDT meetings, patient screenings, outpatient clinics, without overlooking the on-call night shifts. This comprehensive involvement reinforced my confidence and expertise, equipping me for future challenges and opportunities.

What difficulties did you encounter during your fellowship?

As with any move to another country, there are differences rather than difficulties, and I encountered valuable challenges that moulded and refined my professional journey. Every new obstacle became a learning opportunity, bolstering my resilience, confidence, and proficiency, and contributing to an enhanced sense of achievement and progress.

How has your EAPCI Fellowship benefitted your career development?

Post-fellowship, my career witnessed a significant upsurge. The international experience endowed me with a distinctive reputation and a solidified position within Lithuania’s structural heart intervention teams. This foundation facilitated my engagement in clinical trials with new medical devices and first-in-human experiences in structural heart interventions. My endeavour didn’t stop there. I was privileged to win a scholarship from the European Society of Cardiology to pursue the Executive Master’s program in Health Economics, Outcomes, and Management in Cardiovascular Sciences at the prestigious London School of Economics and Political Science, further refining my skills in health economics and management. Now, I actively contribute to the elevation of the healthcare services in Lithuania, applying my accumulated knowledge and fostering international collaborations. My responsibilities as a lecturer at the Faculty of Medicine of the Lithuanian University of Health Sciences, coupled with my full-time clinical role, showcase the comprehensive enhancement of my career and contributions to healthcare. Having successfully earned my PhD, I continue to leverage this academic accomplishment to further amplify my impact in the medical field, underscoring my commitment to advancing healthcare standards both nationally and internationally. Finally, after achieving proficiency in TAVI procedures, I have proudly become a TAVI proctor for many renowned medical companies. This role allows me to share my experiences and skills globally, further enriching the professional community and contributing to the advancement of cardiovascular interventions worldwide.

What advice would you have for future applicants?

Potential EAPCI Fellowship Grant applicants, seize this life-altering opportunity with both hands. This platform is not just a stepping stone for your professional growth but also a chance to make a monumental impact on global cardiovascular healthcare. This journey, while demanding and filled with challenges, will be the catalyst for your extensive learning, growth, and the realisation of your most ambitious dreams in the world of cardiovascular care. Embark on this extraordinary journey, arm yourself with newfound knowledge, and let your contribution resonate worldwide.

Apply now for the 2024 EAPCI Fellowship Grants

https://www.escardio.org/Education/Career-Development/Grants-and-fellowships/EAPCI-interventional-cardiology-training-and-research-grants

Volume 19 Number 11
Dec 18, 2023
Volume 19 Number 11
View full issue

Suggested by Cory

Editorial

10.4244/EIJ-E-25-00022 Sep 15, 2025
An ongoing quest to discern the optimal antithrombotic therapy after TAVI
Hayashida K and Iwata J
free

Translational research

10.4244/EIJ-D-24-01000 Sep 15, 2025
DurAVR – a novel biomimetic balloon-expandable transcatheter valve for TAVI, valve-in-valve TAVI and redo-TAVI
Meier D et al
open access

Research Correspondence

10.4244/EIJ-D-25-00255 Sep 15, 2025
Redo-TAVI with the ACURATE platform for failure of short-frame transcatheter heart valves
Tarantini G et al

Original Research

10.4244/EIJ-D-24-01066 Sep 15, 2025
VARC-HBR criteria validation in TAVI patients on oral anticoagulation
Overduin D et al

Editorial

10.4244/EIJ-E-25-00038 Sep 15, 2025
Evolving cutoff values for optimising left main stenting with intravascular imaging
de la Torre Hernandez J
free

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free

Flashlight

10.4244/EIJ-D-25-00121 Sep 15, 2025
Calcium mapping by 3DStent technology
Amabile N and Benamer H
Trending articles
76.3

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
56.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
56.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
28.25

Clinical research

10.4244/EIJ-D-19-01006 Aug 7, 2020
Coronary collaterals and myocardial viability in patients with chronic total occlusions
Schumacher S et al
free
24.75

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved